Aside from new regulations, the agencies also plan to enforce existing rules around misleading advertising more strictly. The Food and Drug Administration plans to send 100 cease-and-desist letters and thousands of warning letters to companies related to pharmaceutical advertising on Tuesday, a senior administration official said.
